Christine Nash

Christine Nash

Directeur/Membre du Conseil chez RALLYBIO CORPORATION

Fortune : - $ au 31/07/2026

53 ans
Health Technology
Commercial Services
Consumer Services

Profil

Christine A. Nash currently works at Rallybio Corp., as Independent Director from 2022.
Ms. Nash also formerly worked at CoTherix, Inc., as Marketing Director from 2006 to 2007, CM Group LLC, as Director from 2019 to 2022, Eli Lilly & Co., as Principal, Genesoft Pharmaceuticals, Inc., as Product Manager, Chatiemac Consulting LLC, as Principal, Oncology Therapeutics Network Corp., as Principal, Imana, Inc., as Principal, and Hyperion Therapeutics, Inc., as Chief Commercial Officer & Senior Vice President from 2012 to 2015.
Ms. Nash received her undergraduate degree and Masters Business Admin degree from Stanford University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
19/12/2025 0 ( -.--% ) - $ 31/07/2026

Postes actifs de Christine Nash

SociétésPosteDébut
RALLYBIO CORPORATION Directeur/Membre du Conseil 04/04/2022

Anciens postes connus de Christine Nash

SociétésPosteFin
Directeur/Membre du Conseil 01/09/2022
HYPERION THERAPEUTICS INC Corporate Officer/Principal 01/05/2015
Sales & Marketing 01/02/2007
Chatiemac Consulting LLC
Corporate Officer/Principal -
Imana, Inc.
Corporate Officer/Principal -
Voir l'expérience en détail de Christine Nash

Formation de Christine Nash

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

62

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Distribution Services

Technology Services

Imana, Inc.

Health Technology

Chatiemac Consulting LLC

  1. Bourse
  2. Insiders
  3. Christine Nash
🔇